• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2010 年的前列腺癌近距离治疗。

Brachytherapy for prostate cancer in 2010.

机构信息

Department of Urology, Rostock University, Rostock, Germany.

出版信息

Panminerva Med. 2010 Sep;52(3):183-8.

PMID:21045774
Abstract

Permanent prostate brachytherapy by implantation of radioactive isotope seeds has become a widely accepted treatment modality for localized prostate cancer. Clinical outcome data are mature and show excellent long-term PSA recurrence-free survival over 10 years in patients with low risk tumours. Results are dependent on patient selection and implant quality. Preservation of erectile function can be achieved in younger previously potent men and aided by medical treatment.

摘要

放射性同位素种子永久性前列腺近距离放疗已成为局部前列腺癌广泛接受的治疗方式。临床结果数据成熟,显示低危肿瘤患者 10 年以上 PSA 无复发生存率极佳。结果取决于患者选择和植入物质量。对于年轻的、以前有勃起功能的男性,可以通过药物治疗来实现勃起功能的保留。

相似文献

1
Brachytherapy for prostate cancer in 2010.2010 年的前列腺癌近距离治疗。
Panminerva Med. 2010 Sep;52(3):183-8.
2
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.对接受永久性粒子植入治疗的T1-T2期前列腺癌长期预后的多机构分析。
Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):327-33. doi: 10.1016/j.ijrobp.2006.08.056. Epub 2006 Nov 2.
3
Natural history of clinically staged low- and intermediate-risk prostate cancer treated with monotherapeutic permanent interstitial brachytherapy.经单药治疗的临床分期低危和中危前列腺癌的自然史:永久性间质近距离放射治疗。
Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):349-54. doi: 10.1016/j.ijrobp.2009.02.021. Epub 2009 May 19.
4
Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.临床器官局限性前列腺癌的单药近距离放射治疗。
W V Med J. 2005 Jul-Aug;101(4):168-71.
5
Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.挽救性永久性会阴放射性粒子植入术治疗外照射放疗后局限性前列腺腺癌复发
BJU Int. 2009 Sep;104(5):600-4. doi: 10.1111/j.1464-410X.2009.08445.x. Epub 2009 Feb 23.
6
Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy.接受近距离放射治疗的局限性前列腺癌患者的前列腺特异性抗原无复发生存率。
BJU Int. 2004 Dec;94(9):1235-8. doi: 10.1111/j.1464-410X.2004.05149.x.
7
Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.高剂量率近距离放射疗法和外照射治疗前列腺癌的卓越疗效不会因雄激素剥夺而得到改善。
Am J Clin Oncol. 2009 Aug;32(4):342-7. doi: 10.1097/COC.0b013e31818cd277.
8
Undetectable prostate specific antigen at 6-12 months: a new marker for early success in hormonally treated patients after prostate brachytherapy.6至12个月时前列腺特异性抗原检测不到:前列腺近距离放射治疗后接受激素治疗患者早期治疗成功的新标志物。
Cancer. 2005 Jun 15;103(12):2499-506. doi: 10.1002/cncr.21077.
9
Prostate-specific antigen relapse-free survival and side-effects in 734 patients with up to 10 years of follow-up with localized prostate cancer treated by permanent iodine implants.734 例局限性前列腺癌患者永久性碘 125 植入治疗后长达 10 年的随访中前列腺特异抗原无复发生存率和副作用。
BJU Int. 2010 Jul;106(1):32-6. doi: 10.1111/j.1464-410X.2009.09096.x. Epub 2010 Jan 8.
10
Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.单剂量高剂量率近距离放疗和低分割外照射放疗治疗中危前列腺癌:短期和中期毒性及生活质量分析。
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):811-7. doi: 10.1016/j.ijrobp.2009.05.054. Epub 2009 Oct 14.

引用本文的文献

1
Smart sensors for maintaining physiologic homeostasis.用于维持生理稳态的智能传感器。
J Diabetes Sci Technol. 2011 May 1;5(3):470-5. doi: 10.1177/193229681100500301.